U.S., July 16 -- ClinicalTrials.gov registry received information related to the study (NCT07704099) titled 'Safety and Efficacy of KER-065 in Participants With Duchenne Muscular Dystrophy' on July 09.
Brief Summary: The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD), and efficacy of KER-065 administered to adult and pediatric ambulatory and nonambulatory male participants with Duchenne Muscular Dystrophy (DMD) on stable background therapy.
Study Start Date: Sept. 14
Study Type: INTERVENTIONAL
Condition:
Duchenne Muscular Dystrophy
Intervention:
DRUG: KER-065
KER-065 will be administered subcutaneously (SC)
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Keros Therapeuti...